Naclof Unidose (Diclofenac Sodium)

Diclofenac sodium blocks the cyclooxygenase enzymes (COX‑1 and COX‑2) in ocular tissues, which reduces the formation of prostaglandins. Prostaglandins are key mediators of inflammation, swelling, and pain, so their inhibition leads to decreased ocular inflammation and analgesia.

The dosing regimen for Naclof Unidose is determined by the prescribing eye‑care professional based on the specific indication, severity of inflammation, and patient factors. The prescriber will specify the number of drops, frequency, and duration of treatment.

Safety of ocular diclofenac during pregnancy or lactation has not been fully established. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Naclof Unidose, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Naclof Unidose delivers diclofenac sodium, which has a well‑documented anti‑inflammatory profile and rapid onset of action. Compared with other ophthalmic NSAIDs such as ketorolac or bromfenac, diclofenac offers similar efficacy for postoperative inflammation, with a comparable safety profile; choice often depends on clinician preference, formulation availability, and patient tolerance.

Store Naclof Unidose at ambient temperature, preferably below 25 °C, in the original packaging. Protect the container from direct light, moisture, and extreme temperature fluctuations to maintain product stability and potency.

The solution is applied topically to the eye. The patient should wash hands, tilt the head back, gently pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. After dosing, keep the eyes closed for a few seconds to allow absorption and avoid immediate blinking.

Although uncommon, serious adverse events can include corneal ulceration, severe allergic reactions such as angioedema, Stevens‑Johnson syndrome, and significant increases in intra‑ocular pressure. Patients should seek immediate medical attention if they experience persistent pain, vision changes, or signs of an allergic reaction.

Individuals with known hypersensitivity to diclofenac, other NSAIDs, or any component of the formulation should avoid using Naclof Unidose. It is also contraindicated in patients with active ocular infections or uncontrolled intra‑ocular pressure unless specifically directed by an ophthalmologist.